Recombinant Proteus mirabilis Protein CrcB homolog (crcB)

Shipped with Ice Packs
In Stock

Description

Background on Proteus mirabilis

Proteus mirabilis is a significant pathogen in urinary tract infections, especially in individuals with urinary catheters or other urinary tract abnormalities . It is characterized by its ability to form biofilms and produce virulence factors such as hemolysin and urease . The bacterium's swarming behavior is crucial for its pathogenicity and involves complex regulatory systems .

Recombinant Proteins and Their Applications

Recombinant proteins are engineered versions of natural proteins produced through genetic engineering techniques. They are widely used in research, diagnostics, and therapeutics. For instance, recombinant proteins can be used to study protein function, develop vaccines, or create therapeutic agents.

Potential Research Directions

Given the lack of detailed information on the Recombinant Proteus mirabilis Protein CrcB homolog (crcB), potential research directions could include:

  • Functional Analysis: Investigating the protein's role in Proteus mirabilis metabolism or pathogenicity.

  • Structural Studies: Determining the protein's structure to understand its interactions and potential applications.

  • Biotechnological Applications: Exploring its use in biotechnology, such as vaccine development or diagnostic tools.

Data Table: Available Information on Recombinant Proteus mirabilis Protein CrcB Homolog (crcB)

FeatureDescription
Product TypeRecombinant Protein
SpeciesProteus mirabilis
FormLyophilized powder
SizeAvailable in various sizes (e.g., 50 ug)
FunctionNot specifically documented; potential roles in metabolic regulation or stress response
ApplicationsResearch, potential biotechnological uses

References

- GeneBioSystems. Recombinant Proteus mirabilis Protein CrcB homolog(crcB). - Cusabio. Recombinant Proteus mirabilis Protein CrcB homolog (crcB) - Cusabio.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is requested in advance. Additional fees apply for dry ice shipping.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to settle the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The specific tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
crcB; PMI0419; Putative fluoride ion transporter CrcB
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-124
Protein Length
full length protein
Species
Proteus mirabilis (strain HI4320)
Target Names
crcB
Target Protein Sequence
MLNIAIAVFIGGGLGSVLRWLISYRLNSLFPHFATGTLVANCIGAFIIAFGIAWFSKAPN IDPIWKIMLTTGFCGGLTTFSTFSVEVVALFNEGRIGWALGTMGANLAGSFLMTAFAFWL LREM
Uniprot No.

Target Background

Function

Crucial for reducing intracellular fluoride concentration and its associated toxicity.

Database Links

KEGG: pmr:PMI0419

STRING: 529507.PMI0419

Protein Families
CrcB (TC 9.B.71) family
Subcellular Location
Cell inner membrane; Multi-pass membrane protein.

Q&A

What is the Proteus mirabilis CrcB homolog protein?

The CrcB homolog in Proteus mirabilis is a membrane protein believed to function in fluoride ion channel activity and fluoride ion export. It belongs to a conserved family of membrane proteins found across bacteria that play crucial roles in ion homeostasis and potentially in pathogenicity. Similar to other bacterial species, the CrcB homolog likely contributes to fluoride resistance by preventing toxic accumulation of fluoride ions within the bacterial cell. The protein's structure includes multiple transmembrane domains characteristic of ion channel proteins .

How is the crcB gene organized within the P. mirabilis genome?

The crcB gene in P. mirabilis appears to be part of the bacterial genomic architecture that supports pathogenicity. Like other functional genes in P. mirabilis, such as the flaA and flaB flagellin genes, the crcB gene organization likely reflects evolutionary adaptations to the bacterium's ecological niche and pathogenic lifestyle . Understanding its genomic context can provide insights into regulation patterns, which may be environment-dependent similar to the regulatory patterns observed with flagellin genes.

What expression systems are optimal for producing recombinant P. mirabilis CrcB homolog?

For membrane proteins like CrcB, E. coli-based expression systems (particularly BL21(DE3) derivatives) offer a balance of high yield and proper folding. The expression protocol typically involves:

  • Cloning the crcB gene into vectors with strong inducible promoters (pET series)

  • Transformation into expression hosts optimized for membrane proteins

  • Growth at lower temperatures (16-20°C) after induction to facilitate proper folding

  • Induction with reduced IPTG concentrations (0.1-0.5 mM) to prevent inclusion body formation

For challenging membrane proteins, specialized systems incorporating membrane-targeting sequences or fusion partners (MBP, SUMO) can improve solubility and functional expression .

What purification strategies yield the highest purity and activity of recombinant CrcB?

Purification of membrane proteins like CrcB requires specialized approaches:

Purification StepRecommended ConditionsRationale
Cell LysisMechanical disruption with lysozyme (1 mg/ml)Gentle release without denaturing membrane proteins
Membrane IsolationUltracentrifugation (100,000×g, 1 hour)Separates membrane fraction from cytosolic proteins
Solubilizationn-Dodecyl β-D-maltoside (DDM, 1%) or LMNG (0.1%)Preserves protein structure while extracting from membrane
Affinity ChromatographyNi-NTA for His-tagged proteinsCaptures target protein with high specificity
Size ExclusionSuperdex 200 columnRemoves aggregates and yields homogeneous protein

Maintaining the protein in appropriate detergent micelles throughout purification is critical for preserving the native structure and function .

How can I validate the functional activity of recombinant CrcB in vitro?

Functional validation of CrcB can be performed through multiple complementary approaches:

  • Fluoride efflux assays using fluoride-selective electrodes to measure ion transport

  • Liposome reconstitution experiments to assess channel activity in a membrane environment

  • Thermal shift assays to evaluate protein stability and ligand binding

  • Complementation studies in crcB knockout bacterial strains to confirm biological activity

These approaches provide comprehensive assessment of both structural integrity and functional capacity of the recombinant protein .

Does CrcB contribute to antibiotic resistance in P. mirabilis?

While CrcB is not directly identified as an antibiotic resistance determinant, its potential contribution to bacterial survival mechanisms warrants investigation. P. mirabilis strains frequently display multidrug resistance through various mechanisms, including extended-spectrum beta-lactamases (ESBLs) and metallo-β-lactamases (MBLs) . As an ion transport protein, CrcB could indirectly contribute to resistance by:

  • Maintaining ion homeostasis under antibiotic stress conditions

  • Potentially participating in proton-motive force maintenance that affects efflux pump activity

  • Contributing to membrane integrity that affects antibiotic penetration

Research investigating potential interactions between CrcB and known resistance mechanisms could reveal previously unrecognized roles in antimicrobial resistance .

How might CrcB interact with other virulence factors in P. mirabilis?

CrcB may participate in complex regulatory networks that coordinate virulence factor expression. P. mirabilis employs numerous virulence factors including flagella, fimbriae, urease, and two-component regulatory systems . Potential interactions include:

  • Coordination with ion-dependent regulatory systems that control virulence gene expression

  • Integration with stress response pathways during host colonization

  • Contribution to biofilm formation processes by maintaining cellular ion balance

These interactions likely involve two-component regulatory systems similar to the Rcs phosphorelay system (RcsF, RcsC, RcsD, and RcsB) that coordinates multiple virulence mechanisms in P. mirabilis .

Could CrcB be involved in the swarming behavior of P. mirabilis?

P. mirabilis is known for its distinctive swarming motility, a complex differentiation process regulated by numerous factors including flagellar genes (flaA, flaB) . CrcB might participate in this process through:

  • Ion homeostasis maintenance during the metabolically demanding swarming process

  • Potential interactions with flagellar regulatory elements like FlhDC

  • Contribution to cell envelope properties that facilitate swarming differentiation

Similar to how flagellin gene rearrangements affect swarming behavior , changes in crcB expression or function could potentially impact this characteristic virulence-associated behavior.

What controls are essential when studying recombinant CrcB function?

Rigorous experimental controls are critical for membrane protein studies:

  • Protein-free liposomes in transport assays to establish baseline leakage

  • Inactive mutant versions of CrcB (e.g., pore-blocking mutations) to confirm specificity

  • Alternative ion selectivity tests to verify specificity for fluoride versus other anions

  • Expression level normalization when comparing different CrcB variants

  • Detergent-only controls when assessing membrane protein effects

These controls help distinguish specific CrcB activity from experimental artifacts that commonly confound membrane protein research .

How can I design experiments to investigate CrcB's role during infection?

To elucidate CrcB's function during infection, consider these approaches:

  • Generate crcB knockout mutants in P. mirabilis and assess colonization in mouse UTI models

  • Create fluorescent reporter fusions to monitor crcB expression during infection stages

  • Perform competitive infection studies comparing wild-type and crcB-mutant strains

  • Analyze crcB expression under various host-mimicking conditions (urine, pH changes, antimicrobial peptides)

  • Investigate co-infection dynamics with other urinary tract pathogens like Enterococcus faecalis

This experimental framework parallels successful approaches used to characterize other P. mirabilis virulence factors, such as the hydrogenase system genes (fhlA, hyfG) whose roles in colonization were established through similar methods .

What are the challenges in studying membrane proteins like CrcB in P. mirabilis?

Membrane protein research presents several technical challenges:

ChallengePotential SolutionConsideration
Low expression yieldsOptimization of growth conditions and expression parametersMay require extensive screening of conditions
Protein aggregationUse of specialized detergents (LMNG, GDN)Different detergents may affect function
Functional assay limitationsDevelopment of sensitive fluoride-specific detection methodsMay require specialized equipment
Structural determination difficultiesLipid cubic phase crystallization or cryo-EM approachesResource-intensive techniques
Genetic manipulation challengesUse of optimized transformation protocols for P. mirabilisSpecies-specific optimization required

Addressing these challenges requires multidisciplinary approaches combining molecular biology, biochemistry, and structural biology techniques .

What is known about the regulation of crcB expression during P. mirabilis infection cycles?

The regulation of crcB expression likely involves multiple environmental and host-derived signals. While specific information about crcB regulation is limited, parallels can be drawn with other P. mirabilis virulence factors:

  • Two-component systems like QseF may regulate crcB expression in response to environmental cues, similar to how QseF regulates swarming motility through the glmY-qseE-qseG-qseF operon

  • Expression may vary between different infection stages (colonization, biofilm formation, stone formation)

  • Host factors like antimicrobial peptides may trigger regulatory responses affecting crcB expression

  • The Rcs phosphorelay system, known to respond to membrane stress, might influence crcB expression

Future studies employing transcriptomics under infection-mimicking conditions could reveal the regulatory network controlling crcB expression .

How can structural biology approaches advance our understanding of CrcB function?

Advanced structural biology techniques can reveal crucial insights about CrcB:

  • Cryo-electron microscopy to determine the membrane protein structure in near-native environments

  • Molecular dynamics simulations to model fluoride ion movement through the channel

  • Hydrogen-deuterium exchange mass spectrometry to identify dynamic regions involved in gating

  • Site-directed spin labeling EPR to measure conformational changes during ion transport

  • Cross-linking mass spectrometry to identify protein-protein interactions

These approaches would complement functional studies and potentially reveal mechanisms of ion selectivity and transport that could be targeted for therapeutic development .

What are the implications of CrcB function for developing novel antimicrobial strategies?

Understanding CrcB function could lead to novel therapeutic approaches:

  • Development of specific CrcB inhibitors that could compromise bacterial ion homeostasis

  • Exploration of CrcB as a potential vaccine antigen if surface-exposed regions are identified

  • Combination approaches targeting CrcB alongside other virulence factors like urease or flagella

  • Repurposing of existing ion channel modulators as potential antimicrobial adjuvants

Given the increasing prevalence of multidrug-resistant P. mirabilis strains , novel targets like CrcB represent valuable research directions for addressing antibiotic resistance challenges in UTIs and CAUTIs .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.